Cargando…

Reperfusion Strategy of ST-Elevation Myocardial Infarction: A Meta-Analysis of Primary Percutaneous Coronary Intervention and Pharmaco-Invasive Therapy

BACKGROUND: Pharmaco-invasive therapy (PIT), combining thrombolysis and percutaneous coronary intervention, was a potential complement for primary percutaneous coronary intervention (pPCI), while bleeding risk was still a concern. OBJECTIVES: This study aims to compare the efficacy and safety outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kaiyin, Zhang, Bin, Zheng, Bo, Zhang, Yan, Huo, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970601/ https://www.ncbi.nlm.nih.gov/pubmed/35369319 http://dx.doi.org/10.3389/fcvm.2022.813325

Ejemplares similares

Pharmaco‐Invasive Strategy: The Answer to Improving ST‐Elevation–Myocardial Infarction Care
por: Mentias, Amgad, et al.
Publicado: (2020)

Effect of optimized thrombus aspiration on myocardial perfusion and prognosis in acute ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention
por: Xu, Boning, et al.
Publicado: (2023)

Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible
por: Sharma, V
Publicado: (2018)

Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway
por: Jortveit, Jarle, et al.
Publicado: (2021)

Pharmaco-mechanic Antithrombotic Strategies to Reperfusion of the Infarct-Related Artery in Patients with ST-Elevation Acute Myocardial Infarctions
por: Kala, Petr, et al.
Publicado: (2013)

Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Zhao, Li-Hong, et al.
Publicado: (2022)

Effect of Shenfu Injection on Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial
por: Wang, Xiao, et al.
Publicado: (2021)

Association of GSDMD with microvascular-ischemia reperfusion injury after ST-elevation myocardial infarction
por: Sun, Wenjing, et al.
Publicado: (2023)

Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock
por: Wu, Jing, et al.
Publicado: (2022)

Late myocardial reperfusion in ST-elevation myocardial infarction: protocol for a systematic review and meta-analysis
por: Vargas-Fernández, Rodrigo, et al.
Publicado: (2022)

Pre-percutaneous coronary intervention sudden cardiac arrest in ST-elevation myocardial infarction: Incidence, predictors, and related outcomes
por: Machado, Guilherme Pinheiro, et al.
Publicado: (2023)

Prognostic value of myocardial salvage index assessed by cardiovascular magnetic resonance in reperfused ST-segment elevation myocardial infarction
por: Zhang, Shiru, et al.
Publicado: (2022)

Staged revascularization vs. culprit-only percutaneous coronary intervention for multivessel disease in elderly patients with ST-segment elevation myocardial infarction
por: Lang, Jiachun, et al.
Publicado: (2022)

Prognostic significance of myocardial salvage assessed by cardiac magnetic resonance in reperfused ST-segment elevation myocardial infarction
por: Li, Yunling, et al.
Publicado: (2022)

Validation and Comparison of Six Risk Scores for Infection in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Liu, Yuanhui, et al.
Publicado: (2021)

Impact of COVID-19 Pandemic on Mechanical Reperfusion in ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Multicenter Retrospective Study From a Non-epicenter Region
por: Mao, Qi, et al.
Publicado: (2021)

Telemedicine Improves the Short-Term Medical Care of Acute ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention
por: Kamel, Heba, et al.
Publicado: (2021)

Triglyceride-Glucose Index and New-Onset Atrial Fibrillation in ST-Segment Elevation Myocardial Infarction Patients After Percutaneous Coronary Intervention
por: Ling, Yang, et al.
Publicado: (2022)

Triglyceride-glucose index is associated with quantitative flow ratio in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention
por: Yu, Bingyan, et al.
Publicado: (2022)

Short- and long-term survival after ST-elevation myocardial infarction treated with pharmacoinvasive versus primary percutaneous coronary intervention strategy: a prospective cohort study
por: Kvakkestad, Kristin, et al.
Publicado: (2022)

Associations of Lipoprotein(a) With Coronary Atherosclerotic Burden and All-Cause Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
por: Xue, Yuzhou, et al.
Publicado: (2021)

Reperfusion strategy and in-hospital outcomes for ST elevation myocardial infarction in secondary and tertiary hospitals in predominantly rural central China: a multicentre, prospective and observational study
por: Zhang, You, et al.
Publicado: (2021)

Risk Estimation for Infection in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Development and Validation of a Predictive Score
por: Liu, Yuanhui, et al.
Publicado: (2022)

Association between admission-blood-glucose-to-albumin ratio and clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
por: Zhen, Cien, et al.
Publicado: (2023)

Impact of coronary collaterals on in-hospital and 5-year mortality after ST-elevation myocardial infarction in the contemporary percutaneous coronary intervention era: a prospective observational study
por: Hara, Masahiko, et al.
Publicado: (2016)

Prognosis Between ST-Elevation and Non-ST-elevation Myocardial Infarction in Older Adult Patients
por: Chang, Shih-Sheng, et al.
Publicado: (2022)

Long-term prognostic value of macrophage migration inhibitory factor in ST-segment elevation myocardial infarction patients with metabolic syndrome after percutaneous coronary intervention
por: Yu, Xiao-Lin, et al.
Publicado: (2022)

Effects of ischaemic postconditioning on outcomes of patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention: a meta-analysis
por: Xing, Zhenhua, et al.
Publicado: (2019)

Clinical Impact of Thrombus Aspiration and Interaction With D-Dimer Levels in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Li, Jun-feng, et al.
Publicado: (2021)

Predicting value of white cell count and total bilirubin on clinical outcomes in patients with ST-elevation myocardial infarction following percutaneous coronary intervention: a cohort study
por: Tuxun, Munire, et al.
Publicado: (2020)

Use of the Thrombolysis in Myocardial Infarction Risk Index for Elderly Patients With ST-Segment Elevation Myocardial Infarction
por: Fu, Bingqi, et al.
Publicado: (2021)

Clinical efficacy of sacubitril-valsartan combined with acute ST-segment elevation myocardial infarction after reperfusion: A systematic review and meta-analysis
por: Zhang, Dong, et al.
Publicado: (2022)

Case Report: ST-Elevation Myocardial Infarction Secondary to Acute Atherothrombotic Occlusion Treated With No Stent Strategy
por: Dhawan, Rahul, et al.
Publicado: (2022)

Out-of-hours primary percutaneous coronary intervention for ST-elevation myocardial infarction is not associated with excess mortality: a study of 3347 patients treated in an integrated cardiac network
por: Rathod, Krishnaraj S, et al.
Publicado: (2013)

Multivessel vs. Culprit Vessel-Only Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction in Patients With Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis
por: Xiong, Bingquan, et al.
Publicado: (2022)

Intracoronary artery retrograde thrombolysis combined with percutaneous coronary interventions for ST-segment elevation myocardial infarction complicated with diabetes mellitus: A case report and literature review
por: Shen, Mingzhi, et al.
Publicado: (2022)

Validity of regional network systems on reperfusion therapy in diabetes mellitus and non-diabetes mellitus patients with ST-segment elevation myocardial infarction
por: Li, Xicong, et al.
Publicado: (2022)

Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study
por: Yu, Xiao-Fan, et al.
Publicado: (2022)

Relationship Between Different Risk Factor Patterns and Follow-Up Outcomes in Patients With ST-Segment Elevation Myocardial Infarction
por: Chen, Si, et al.
Publicado: (2021)

Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction
por: Fang, Caoyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jhkbijsskrq630lqcgqo41f2fp